• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

Lung Cancer Research Foundation Awards $2.1 Million In Grants To Further Critical Research

28 Grants will Fund Lung Cancer Research Efforts at 22 Institutions


News provided by

Lung Cancer Research Foundation

Oct 30, 2015, 09:11 ET

Share this article

Share this article


Lung Cancer Research Foundation Logo
Lung Cancer Research Foundation Logo

NEW YORK, Oct. 30, 2015 /PRNewswire-USNewswire/ -- The Lung Cancer Research Foundation (LCRF) awarded a record $2.1 million in research grants at its 10th Annual Lung Cancer Awareness Luncheon on Thursday, October 29, at The Pierre Hotel in New York City. In total, the organization awarded 28 grants as part of its 2015 Scientific Grant Program which is designed to fund projects across the spectrum of basic, clinical and translational research in lung cancer.

"LCRF is proud to recognize the outstanding efforts of our 2015 grant recipients," said Nancy Sanford, Executive Director, LCRF. "We believe that these groundbreaking research projects will greatly contribute to the advancement of innovative strategies to prevent and treat lung cancer, the number one cause of cancer death worldwide."

Among those newly awarded is Wen Xue, PhD, assistant professor at the RNA Therapeutics Institute at the University of Massachusetts Medical School. Dr. Xue also received the LCRF Scientific Merit Award, which acknowledges the investigator whose proposal was selected for outstanding overall merit by the Foundation's Scientific Advisory Board. Dr. Xue received the accolade for his research targeting small RNA-mediated KRAS inhibition in lung cancer.

"Continued support for lung cancer research is critical to driving advancements in the field. I'm thankful to LCRF for believing in this important research, which will potentially lead to better patient outcomes." said Dr. Xue.

Dr. Carla F. Kim, PhD, principal investigator at Boston Children's Hospital Stem Cell Program and associate professor of genetics and pediatrics at Harvard Medical School, received the William Rippe Award for Distinguished Research in Lung Cancer for her project regarding precision medicine opportunities for BRG1 deficient lung cancers.

The 2015 grant recipients were selected from a pool of more than 140 applications from 92 institutions in 19 countries. The maximum award amount is $75,000 for a period of one year. The 2015 LCRF grant recipients are:

John Brognard, PhD, University of Manchester
TNIK: a novel and druggable driver in lung squamous cell carcinoma

Alexander Drilon, MD, Memorial Sloan Kettering Cancer Center
Targeting lung adenocarcinoma with MET exon 14 skipping mutations and defining mechanisms of sensitivity and resistance to therapy

Daniel Gomez, MD, The University of Texas MD Anderson Cancer Center
Intratumoral heterogeneity analysis as a method for identifying drivers and mechanisms of metastasis in non-small cell lung cancer

Emanuela Grassilli, PhD, University of Milano-Bicocca
Development of a novel diagnostic and therapeutic target in non-small cell lung cancer

Wesley Hsu, MD, Wake Forest University Health Sciences
Inhibition of FGFR1/MAPK signaling to downregulate brachyury for the treatment of lung cancer

Paul Huang, PhD, The Institute of Cancer Research
Investigating kinase dependencies in BRG1-deficient lung cancer

Benjamin Izar, MD, PhD, Dana-Farber Cancer Institute
Dissecting treatment-resistance to EGFR-inhibitors in lung cancer patients using single-cell RNA-sequencing

Duangporn Jamsai, PhD, Monash University
RBM5 is a critical regulator of pre-mRNA splicing and a lung tumor suppressor

Natalia Jura, PhD, University of California, San Francisco
Molecular basis for the activation of Met receptor in lung cancer by mutations in the juxtamembrane segment

Vaishali Kapoor, PhD, Washington University in St. Louis
Immunotherapy targeting radiation-induced neoantigens, a novel strategy to treat lung cancer

Carla Kim, PhD, Boston Children's Hospital
Precision medicine opportunities for BRG1 deficient lung cancers

Donald Kufe, MD, Dana-Farber Cancer Institute
Targeting the MUC1-C oncoprotein with new agents in drug resistant NSCLC

Vincent Lam, MD, University of Maryland, Baltimore
Genomic analysis of pan-wild type metastatic lung adenocarcinoma (LUAD) exceptional responders

Leanne Li, MD, PhD, Massachusetts Institute of Technology
It takes two to tango: Dissecting the molecular mechanisms by which intra-tumoral heterogeneity contributes to small cell lung cancer metastasis

Linde Miles, Memorial Sloan Kettering Cancer Center
Characterization of ANTXR1 as the cellular receptor for Seneca Valley Virus

Matthew Niederst, PhD, Massachusetts General Hospital
Combining 1st plus 3rd generation EGFR inhibitors to maximize response in EGFR mutant NSCLC patients

Manish Patel, DO, University of Minnesota
Combination oncolytic virotherapy and immune checkpoint blockade for non-small cell lung cancer

Janey Peterson, PhD, Weill Cornell Medical College
Strides for life I: A randomized controlled trial of induction of positive affect to increase physical activity in early stage lung cancer survivors

Saleela Ruwanpura, PhD, Hudson Institute of Medical Research
Interleukin-6 trans-signalling as a novel therapeutic target and a biomaker for lung cancer

Kurt Schalper, MD, PhD, Yale University
Quantitative analysis of the PD-1 axis components and immune infiltrates in lung cancer: predictive role and therapeutic implications

Tuomas Tammela, MD, PhD, Massachusetts Institute of Technology
Targeting cellular heterogeneity in lung cancer with novel therapeutics

Joana Vidigal, PhD, Memorial Sloan Kettering Cancer Center
Investigating the role of mutations in epigenetic regulators and non coding DNA elements in lung cancer

Victoria Wang, MD, PhD, University of California, San Francisco
Tumor recurrence and drug resistance in non-small cell lung cancer through modulation of the cytoskeleton and Induction of YAP1

Ralph Weichselbaum, MD, The University of Chicago
Detection of RNAs activated by ionizing radiation and their radiosensitizing effects in lung cancer cells and tumors

Wen Xue, PhD, University of Massachusetts Medical School
Small RNA-mediated KRAS inhibition in lung cancer

David Yu, MD, PhD, Emory University
Exploiting the replication stress response in small cell lung cancer

Bruce Zetter, PhD, Boston Children's Hospital
The mechanistic role of prohibitin 1 in non-small cell lung cancer chemoresistance

Xiaorong Zhou, PhD, University of Texas Southwestern Medical Center   
Molecular characterization of the PCDH7/SET pathway in non-small-cell lung cancer

Additional information about the LCRF Grant Program, can be found at http://www.lungcancerresearchfoundation.org/our-research/grant-applicants.             

About The Lung Cancer Research Foundation
The mission of the Lung Cancer Research Foundation is to improve and save lives by funding groundbreaking research for the prevention, diagnosis, treatment and cure of lung cancer. In 2015, the original Lung Cancer Research Foundation and Uniting Against Lung Cancer merged to form the Foundation as it is today, combining their expertise, resources and networks to have an even greater impact on the disease. Since inception, the two organizations have funded hundreds of grants across the spectrum of basic, clinical and translational research at leading medical institutions around the world.

Contact:
Delia Naughton,
[email protected], 212-588-1580

Logo - http://photos.prnewswire.com/prnh/20131101/DC09073LOGO

SOURCE Lung Cancer Research Foundation

Related Links

http://www.lungfund.org

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.